Product
Longeveron Mesenchymal Stem Cells
Aliases
Longeveron Mesenchymal Stem Cells (LMSCs)
3 clinical trials
5 indications
Indication
ARDSIndication
HumanIndication
COVID-19Indication
Aging FrailtyIndication
Hypoplastic Left Heart SyndromeClinical trial
A Phase 1 Double-blinded, Randomized, Placebo-controlled Study for COVID-19 and Influenza Virus-Elicited Acute Respiratory Distress Syndrome (ARDS) Using Lomecel-BStatus: Active (not recruiting), Estimated PCD: 2024-06-01
Clinical trial
Effects of Intravenous Delivery of Lomecel-B (Formerly Allogenic Longeveron Human Mesenchymal Stem Cells (LMSCs)) on VaccinE-Specific Antibody Responses in Subjects With Aging FrailtyStatus: Completed, Estimated PCD: 2021-09-01
Clinical trial
Lomecel-B Injection in Patients With Hypoplastic Left Heart Syndrome: A Phase I/II Study (ELPIS)Status: Active (not recruiting), Estimated PCD: 2024-06-30